VCYT

SEC source: 0001437749-20-024888 · rdgdoc.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,443

F1 · kind: The reporting person is reporting the withholding of 988 and 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 and 1,875 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person.

SEC source: 0001437749-20-024886 · rdgdoc.xml · nonDerivative · entry 1

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,844

F1 · kind: The reporting person is reporting the withholding of 217 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively and does not represent a sale by the reporting person.

SEC source: 0001437749-20-024884 · rdgdoc.xml · nonDerivative · entry 1

Kennedy Keith · CIK 0001543503 · COO / CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,117

F1 · kind: The reporting person is reporting the withholding of 440, 284 and 220 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,000, 644 and 500 Restricted Stock Units, respectively granted on July 1, 2019, March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person.

SEC source: 0001437749-20-024881 · rdgdoc.xml · nonDerivative · entry 1

Ho Mark · CIK 0001554165 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,934

F1 · kind: The reporting person is reporting the withholding of 65 and 87 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 187 and 250 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person.

SEC source: 0001437749-20-023860 · rdgdoc.xml · derivative · entry 4

GORDON KEVIN K · CIK 0001218483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 10,000 shares

Expires 2026-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.

F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on December 12, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-023860 · rdgdoc.xml · nonDerivative · entry 3

GORDON KEVIN K · CIK 0001218483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $47.56 to $48.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023860 · rdgdoc.xml · nonDerivative · entry 2

GORDON KEVIN K · CIK 0001218483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,806

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.50 to $47.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023860 · rdgdoc.xml · nonDerivative · entry 1

GORDON KEVIN K · CIK 0001218483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.

SEC source: 0001437749-20-023855 · rdgdoc.xml · nonDerivative · entry 1

Ho Mark · CIK 0001554165 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,086

SEC source: 0001437749-20-023673 · rdgdoc.xml · derivative · entry 11

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,312

Underlying: Common Stock · 20,000 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F7 · derivative.exercise_date: The option is fully vested.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 9

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · MJP Anderson Trust

Disclosed balance after: 47,906

F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, if any.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 8

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · The ANP Anderson Trust

Disclosed balance after: 47,906

F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, if any.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 7

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,419

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 6

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,325

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 5

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.51 to $43.88. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 4

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.50 to $43.50. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 3

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $41.47 to $42.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 2

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,238

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.41 to $41.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023673 · rdgdoc.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

SEC source: 0001437749-20-023244 · rdgdoc.xml · derivative · entry 4

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,750

Underlying: Common Stock · 21,250 shares

Expires 2029-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-023244 · rdgdoc.xml · nonDerivative · entry 3

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,309

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $44.03 to $44.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023244 · rdgdoc.xml · nonDerivative · entry 2

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,509

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.00 to $44.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023244 · rdgdoc.xml · nonDerivative · entry 1

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

SEC source: 0001437749-20-023003 · rdgdoc.xml · derivative · entry 7

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,782

Underlying: Common Stock · 3,281 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F6 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-023003 · rdgdoc.xml · derivative · entry 6

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,292

Underlying: Common Stock · 3,125 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-023003 · rdgdoc.xml · nonDerivative · entry 5

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,309

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.05 to $42.13. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023003 · rdgdoc.xml · nonDerivative · entry 4

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,442

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $41.01 to $42.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023003 · rdgdoc.xml · nonDerivative · entry 3

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,102

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $39.95 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-023003 · rdgdoc.xml · nonDerivative · entry 2

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

SEC source: 0001437749-20-023003 · rdgdoc.xml · nonDerivative · entry 1

Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,434

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.

SEC source: 0001437749-20-021431 · rdgdoc.xml · derivative · entry 2

Ho Mark · CIK 0001554165 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested.

SEC source: 0001437749-20-021431 · rdgdoc.xml · nonDerivative · entry 1

Ho Mark · CIK 0001554165 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-20-021350 · rdgdoc.xml · derivative · entry 2

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested.

SEC source: 0001437749-20-021350 · rdgdoc.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-20-021004 · rdgdoc.xml · derivative · entry 6

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,312

Underlying: Common Stock · 50,000 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0001437749-20-021004 · rdgdoc.xml · nonDerivative · entry 2

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,231

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

SEC source: 0001437749-20-021004 · rdgdoc.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

SEC source: 0001437749-20-020855 · rdgdoc.xml · derivative · entry 3

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 2,500 shares

Expires 2029-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-020855 · rdgdoc.xml · nonDerivative · entry 2

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,399

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

SEC source: 0001437749-20-020855 · rdgdoc.xml · nonDerivative · entry 1

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

SEC source: 0001437749-20-019683 · rdgdoc.xml · derivative · entry 7

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,312

Underlying: Common Stock · 20,000 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F5 · derivative.exercise_date: The option is fully vested.

SEC source: 0001437749-20-019683 · rdgdoc.xml · nonDerivative · entry 3

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,231

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $31.12 to $31.95. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-019683 · rdgdoc.xml · nonDerivative · entry 2

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,838

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.11 to $31.11. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-019683 · rdgdoc.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

SEC source: 0001437749-20-019416 · rdgdoc.xml · derivative · entry 7

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,438

Underlying: Common Stock · 2,937 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-019416 · rdgdoc.xml · derivative · entry 6

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,625

Underlying: Common Stock · 3,542 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

SEC source: 0001437749-20-019416 · rdgdoc.xml · nonDerivative · entry 5

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,399

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $31.78 to $32.67. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-019416 · rdgdoc.xml · nonDerivative · entry 4

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,540

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.69 to $31.68. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-019416 · rdgdoc.xml · nonDerivative · entry 3

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,890

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.58 to $30.49. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001437749-20-019416 · rdgdoc.xml · nonDerivative · entry 2

Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.